S. Sakajiri

发表

Molecular Analysis of Tumor Suppressor Genes, Rb, p53,pl6INK4A, pl5INK4B and p14ARF in Natural Killer Cell Neoplasms

K. Oshimi, N. Kawamata, S. Sakajiri, 2001, Japanese journal of cancer research : Gann.

Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma

S. Sakajiri, T. Sakurai, Y. Mishima, 2009, Clinical Cancer Research.

Identification of CD 20 C-Terminal DeletionMutations Associated with Loss of CD 20 Expression in Non-Hodgkin ’ s Lymphoma

S. Sakajiri, T. Sakurai, K. Takeuchi, 2009 .

B-cell Marker Negative (CD7 +, CD19 − ) Epstein-Barr Virus-related Pyothorax-associated Lymphoma with Rearrangement in the JH Gene

K. Oshimi, S. Sakajiri, Kiyoshi L Mori, 2003, Leukemia & lymphoma.

Epstein–Barr virus‐associated T‐cell acute lymphoblastic leukaemia

K. Oshimi, N. Kawamata, S. Sakajiri, 2002, British journal of haematology.

A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors

H. Tanii, S. Sakajiri, Ken Kobayashi, 2012, Investigational New Drugs.

Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis

Y. Hamano, S. Sakajiri, Y. Fukuda, 2020, Journal of clinical and experimental hematopathology : JCEH.

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone

N. Nishimura, S. Sakajiri, Kazuhito Suzuki, 2013, Leukemia & lymphoma.

DLK1: increased expression in gliomas and associated with oncogenic activities

D. Xie, K. Black, C. Miller, 2006, Oncogene.

Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients.

N. Nishimura, S. Sakajiri, Kazuhito Suzuki, 2014, Japanese journal of clinical oncology.

Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy

N. Nishimura, S. Sakajiri, K. Takeuchi, 2013, Leukemia & lymphoma.

Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan

K. Ozawa, N. Nishimura, S. Sakajiri, 2013, ISRN oncology.

Relapsed refractory nodal peripheral T-cell lymphoma with follicular helper T-cell phenotype was initially resistant to pralatrexate and confirmed to be unresponsive to subsequent forodesine, but responded to re-instituted pralatrexate

N. Komatsu, Y. Hamano, S. Sakajiri, 2020, Journal of clinical and experimental hematopathology : JCEH.

Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study

H. Ohno, M. Murakami, Takeshi Takahashi, 2019, International Journal of Hematology.

Dlk1 in normal and abnormal hematopoiesis

L. Shih, W. Hofmann, H. Koeffler, 2005, Leukemia.

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

Y. Ishikawa, N. Nishimura, S. Sakajiri, 2012, Japanese journal of clinical oncology.

Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders

K. Oshimi, N. Kawamata, S. Sakajiri, 2005, European journal of haematology.

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma

N. Nishimura, S. Sakajiri, Kazuhito Suzuki, 2012, Experimental Hematology & Oncology.

Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study

Toshio Shimizu, S. Sakajiri, T. Koyama, 2021, Cancer science.

A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4

K. Oshimi, N. Kawamata, S. Sakajiri, 2002, Oncogene.

Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.

H. Koeffler, N. Kawamata, S. Sakajiri, 2005, Experimental hematology.

Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms

K. Oshimi, N. Kawamata, S. Sakajiri, 2002, Japanese journal of cancer research : Gann.

Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.

N. Nishimura, S. Sakajiri, Kazuhito Suzuki, 2013, Japanese journal of clinical oncology.

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.

D. Ennishi, M. Tanimoto, S. Sakajiri, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study

T. Yamauchi, S. Sakajiri, I. Choi, 2019, International Journal of Hematology.

High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone

N. Nishimura, S. Sakajiri, Kazuhito Suzuki, 2012, Leukemia & lymphoma.

Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow.

H. Koeffler, K. Oshimi, N. Kawamata, 2005, International journal of oncology.

Identification of Candidate Tumor Suppressor Genes Silenced Epigenetically in Mantle Cell Lymphoma.

P. Koeffler, N. Kawamata, S. Sakajiri, 2005 .

Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD)

Y. Hamano, S. Sakajiri, Y. Fukuda, 2020, Internal medicine.

[Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I].

S. Sakajiri, Y. Mishima, T. Saotome, 2010, Gan to kagaku ryoho. Cancer & chemotherapy.